$1.1 Billion Worldwide Liquid Biopsy Industry to 2027 – US Market is Estimated at $315 Million – ResearchAndMarkets.com

$1.1 Billion Worldwide Liquid Biopsy Industry to 2027 – US Market is Estimated at $315 Million – ResearchAndMarkets.com




$1.1 Billion Worldwide Liquid Biopsy Industry to 2027 – US Market is Estimated at $315 Million – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Liquid Biopsy – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.

Amid the COVID-19 crisis, the global market for Liquid Biopsy estimated at US$1.1 Billion in the year 2020, is projected to reach a revised size of US$3.8 Billion by 2027, growing at a CAGR of 20.2% over the analysis period 2020-2027.

Lung, one of the segments analyzed in the report, is projected to record a 20.5% CAGR and reach US$1.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Breast segment is readjusted to a revised 21.5% CAGR for the next 7-year period.

The U.S. Market is Estimated at $315 Million, While China is Forecast to Grow at 19.8% CAGR

The Liquid Biopsy market in the U.S. is estimated at US$315 Million in the year 2020. China, the world’s second largest economy, is forecast to reach a projected market size of US$672.3 Million by the year 2027 trailing a CAGR of 19.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 18.1% and 17.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 14.1% CAGR.

Colorectal Segment to Record 19.5% CAGR

In the global Colorectal segment, USA, Canada, Japan, China and Europe will drive the 19.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$144.5 Million in the year 2020 will reach a projected size of US$502.3 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$447.7 Million by the year 2027.

Select Competitors (Total 42 Featured):

  • Biocept, Inc.
  • Bio-Rad Laboratories, Inc.
  • Genomic Health, Inc.
  • Guardant Health, Inc.
  • Illumina, Inc.
  • MDxHealth SA
  • Menarini Silicon Biosystems Spa
  • Myriad Genetics, Inc.
  • Qiagen NV
  • RainDance Technologies, Inc.
  • Roche Diagnostics (Schweiz) AG
  • Thermo Fisher Scientific, Inc.
  • TrovaGene, Inc.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession

III. MARKET ANALYSIS

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/intzm2

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900